Inflammatory biomarker response to GLP-1 receptor agonists versus other glucose-lowering medications in patients with type 2 diabetes: a systematic review and meta-analysis

Authors

Institutions

Publication Details

Journal
Frontiers in Endocrinology
Published
2026-01-15
DOI
https://doi.org/10.3389/fendo.2025.1734549
Primary Topic
Diabetes Treatment and Management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Inflammatory biomarker response to GLP-1 receptor agonists versus other glucose-lowering medications in patients with type 2 diabetes: a systematic review and meta-analysis

Hesham A. Khairy, Tariq Alrasheed, Mohamed E. A. Mostafa, Mohammed A Madkhali
Frontiers in Endocrinology
Diabetes Treatment and Management
article

Inflammatory biomarker response to GLP-1 receptor agonists versus other glucose-lowering medications in patients with type 2 diabetes: a systematic review and meta-analysis

Hesham A. Khairy, Tariq Alrasheed, Mohamed E. A. Mostafa, Mohammed A Madkhali
article en

Abstract

No abstract available for this paper.
Frontiers in EndocrinologyVol. 16
Imam Mohammad ibn Saud Islamic University (SA), University of the Ryukyus (JP), Islamic University (BD), University of Tabuk (SA), Jazan University (SA)
Good health and well-being
Openalex Percentile: Top 88%
Diabetes Treatment and Management
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.